Patents by Inventor Carles Ubeda

Carles Ubeda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10226443
    Abstract: Methods, agents and compositions thereof for treating psoriatic arthritis (PsA) are encompassed herein.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: March 12, 2019
    Assignees: New York University, Memorial Sloan-Kettering Cancer Center, Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana (Fisabio)
    Inventors: Jose U. Scher, Carles Ubeda, Dan R. Littman, Eric G. Pamer, Steven B. Abramson, Sergei B. Koralov
  • Publication number: 20160186261
    Abstract: Methods, reagents and compositions thereof for predicting risk for NORA onset in susceptible individuals, diagnosing NORA onset, and/or evaluating efficacy of a therapeutic regimen for treating RA are described herein. Determining the amount of at least one of SEQ ID NOs: 1-19 and/or at least one of a KO presented in either of Tables S4 or S5 serves as a biomarker for the above indications.
    Type: Application
    Filed: November 4, 2014
    Publication date: June 30, 2016
    Inventors: Jose U. Scher, Andrew Sczesnak, Randy S. Longman, Nicola Segata, Carles Ubeda, Eric G. Pamer, Steven B. Abramson, Curtis Huttenhower, Dan R. Littman, Hannah Fehlner-Peach
  • Publication number: 20160136122
    Abstract: Methods, agents and compositions thereof for treating psoriatic arthritis (PsA) are encompassed herein.
    Type: Application
    Filed: October 16, 2015
    Publication date: May 19, 2016
    Inventors: Jose U. Scher, Carles Ubeda, Dan R. Littman, Eric G. Pamer, Steven B. Abramson, Sergei B. Koralov
  • Publication number: 20150374760
    Abstract: Methods, agents and compositions thereof for treating psoriatic arthritis (PsA) and psoriasis (Ps) are encompassed herein, as are methods for identifying pathogenic dysbiosis in a subject, the presence of which is a positive indicator of risk for developing PsA or of the presence of PsA in a subject with arthritic symptoms.
    Type: Application
    Filed: April 9, 2015
    Publication date: December 31, 2015
    Inventors: Jose U. Scher, Carles Ubeda, Dan R. Littman, Eric G. Pamer, Steven B. Abramson